The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma
Rhabdomyosarcoma is a highly aggressive malignant cancer that arises from skeletal muscle progenitor cells and is the third most common solid tumour in children. Despite significant advances, rhabdomyosarcoma still presents a therapeutic challenge, and while targeted therapy has shown promise, there...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
MDPI
2020
|
| _version_ | 1797109958565691392 |
|---|---|
| author | Sims, D Maranyane, HM Damerell, V Govender, D Isaacs, AW Peres, J Prince, S |
| author_facet | Sims, D Maranyane, HM Damerell, V Govender, D Isaacs, AW Peres, J Prince, S |
| author_sort | Sims, D |
| collection | OXFORD |
| description | Rhabdomyosarcoma is a highly aggressive malignant cancer that arises from skeletal muscle progenitor cells and is the third most common solid tumour in children. Despite significant advances, rhabdomyosarcoma still presents a therapeutic challenge, and while targeted therapy has shown promise, there are limited options because the molecular drivers of rhabdomyosarcoma are poorly understood. We previously reported that the T-box transcription factor 3 (TBX3), which has been identified as a druggable target in many cancers, is overexpressed in rhabdomyosarcoma patient samples and cell lines. To identify new molecular therapeutic targets to treat rhabdomyosarcoma, this study investigates the potential oncogenic role(s) for TBX3 and the factors responsible for upregulating it in this cancer. To this end, rhabdomyosarcoma cell culture models in which TBX3 was either stably knocked down or overexpressed were established and the impact on key hallmarks of cancer were examined using growth curves, soft agar and scratch motility assays, as well as tumour-forming ability in nude mice. Our data show that TBX3 promotes substrate-dependent and -independent proliferation, migration and tumour formation. We further reveal that TBX3 is upregulated by c-Myc transcriptionally and AKT1 post-translationally. This study identifies c-Myc/AKT1/TBX3 as an important axis that could be targeted for the treatment of rhabdomyosarcoma. |
| first_indexed | 2024-03-07T07:48:29Z |
| format | Journal article |
| id | oxford-uuid:6e812734-9db6-4f3f-a2ea-26829f4c1440 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:48:29Z |
| publishDate | 2020 |
| publisher | MDPI |
| record_format | dspace |
| spelling | oxford-uuid:6e812734-9db6-4f3f-a2ea-26829f4c14402023-06-21T15:55:12ZThe c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcomaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6e812734-9db6-4f3f-a2ea-26829f4c1440EnglishSymplectic ElementsMDPI2020Sims, DMaranyane, HMDamerell, VGovender, DIsaacs, AWPeres, JPrince, SRhabdomyosarcoma is a highly aggressive malignant cancer that arises from skeletal muscle progenitor cells and is the third most common solid tumour in children. Despite significant advances, rhabdomyosarcoma still presents a therapeutic challenge, and while targeted therapy has shown promise, there are limited options because the molecular drivers of rhabdomyosarcoma are poorly understood. We previously reported that the T-box transcription factor 3 (TBX3), which has been identified as a druggable target in many cancers, is overexpressed in rhabdomyosarcoma patient samples and cell lines. To identify new molecular therapeutic targets to treat rhabdomyosarcoma, this study investigates the potential oncogenic role(s) for TBX3 and the factors responsible for upregulating it in this cancer. To this end, rhabdomyosarcoma cell culture models in which TBX3 was either stably knocked down or overexpressed were established and the impact on key hallmarks of cancer were examined using growth curves, soft agar and scratch motility assays, as well as tumour-forming ability in nude mice. Our data show that TBX3 promotes substrate-dependent and -independent proliferation, migration and tumour formation. We further reveal that TBX3 is upregulated by c-Myc transcriptionally and AKT1 post-translationally. This study identifies c-Myc/AKT1/TBX3 as an important axis that could be targeted for the treatment of rhabdomyosarcoma. |
| spellingShingle | Sims, D Maranyane, HM Damerell, V Govender, D Isaacs, AW Peres, J Prince, S The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title | The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title_full | The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title_fullStr | The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title_full_unstemmed | The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title_short | The c-Myc/AKT1/TBX3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| title_sort | c myc akt1 tbx3 axis is important to target in the treatment of embryonal rhabdomyosarcoma |
| work_keys_str_mv | AT simsd thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT maranyanehm thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT damerellv thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT govenderd thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT isaacsaw thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT peresj thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT princes thecmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT simsd cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT maranyanehm cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT damerellv cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT govenderd cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT isaacsaw cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT peresj cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma AT princes cmycakt1tbx3axisisimportanttotargetinthetreatmentofembryonalrhabdomyosarcoma |